Fc-binding antibody-recruiting molecules exploit endogenous antibodies for anti-tumor immune responses

Redirecting endogenous antibodies in the bloodstream to tumor cells using synthetic molecules is a promising approach to trigger anti-tumor immune responses. However, current molecular designs only enable the use of a small fraction of endogenous antibodies, limiting the therapeutic potential. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Koichi, Harada, Minori, Miyashita, Yoshiki, Tagawa, Hiroshi, Kishimura, Akihiro, Mori, Takeshi, Katayama, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157400/
https://www.ncbi.nlm.nih.gov/pubmed/34122826
http://dx.doi.org/10.1039/d0sc00017e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157400/
https://www.ncbi.nlm.nih.gov/pubmed/34122826
http://dx.doi.org/10.1039/d0sc00017e

Ejemplares similares